Works matching IS 0741238X AND DT 2022 AND VI 39 AND IP 8
Results: 32
A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3488, doi. 10.1007/s12325-022-02223-0
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Response to: Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Quality of Life of Japanese Dysmenorrhea/Heavy Menstrual Bleeding Patients Treated with Levonorgestrel Intrauterine Delivery System in a Real-World Setting.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3616, doi. 10.1007/s12325-022-02205-2
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Correction to: Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3789, doi. 10.1007/s12325-022-02206-1
- By:
- Publication type:
- Article
Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3735, doi. 10.1007/s12325-022-02212-3
- By:
- Publication type:
- Article
US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3696, doi. 10.1007/s12325-022-02204-3
- By:
- Publication type:
- Article
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3547, doi. 10.1007/s12325-022-02202-5
- By:
- Publication type:
- Article
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparative Analysis of All-Cause Health Care Resource Utilization and Costs Among Venous Thrombosis Patients Without Cancer Prescribed Apixaban or VKAs in France.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1–84): A Retrospective Cohort Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3845, doi. 10.1007/s12325-022-02198-y
- By:
- Publication type:
- Article
A Retrospective Observational Study Examining the Generalizability of Glucagon-Like Peptide 1 Receptor Agonist Cardiovascular Outcome Trials to the Real-World Population with Type 2 Diabetes in Spain: The REPRESENT Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3589, doi. 10.1007/s12325-022-02196-0
- By:
- Publication type:
- Article
Triplet RVd Induction for Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3654, doi. 10.1007/s12325-022-02194-2
- By:
- Publication type:
- Article
Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3425, doi. 10.1007/s12325-022-02193-3
- By:
- Publication type:
- Article
Benign Peripheral Non-cranial Nerve Sheath Tumors of the Neck.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3449, doi. 10.1007/s12325-022-02191-5
- By:
- Publication type:
- Article
Improved Prediction of Body Mass Index in Real-World Administrative Healthcare Claims Databases.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3835, doi. 10.1007/s12325-022-02192-4
- By:
- Publication type:
- Article
Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3560, doi. 10.1007/s12325-022-02188-0
- By:
- Publication type:
- Article
Achieving Lower LDL-C Levels After a Recent Myocardial Infarction Might Be Associated with Lower Healthcare Resource Use and Costs in Spain.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3578, doi. 10.1007/s12325-022-02187-1
- By:
- Publication type:
- Article
Clinical Radiofrequency Ablation Outcomes of Combined Sensory Nerve Branch and Dorsal Entry Root Zone Complex Lesions for Sacroiliac Joint Complex Pain.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3539, doi. 10.1007/s12325-022-02183-5
- By:
- Publication type:
- Article
It is Time to Replace Large Drains with Small Ones After Fixation of Rib Fractures: A Prospective Observational Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK).
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3602, doi. 10.1007/s12325-022-02177-3
- By:
- Publication type:
- Article
Budget Impact and Cost-Effectiveness of Intravenous Meloxicam to Treat Moderate–Severe Postoperative Pain.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3524, doi. 10.1007/s12325-022-02174-6
- By:
- Publication type:
- Article
Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3711, doi. 10.1007/s12325-022-02173-7
- By:
- Publication type:
- Article
Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3472, doi. 10.1007/s12325-022-02169-3
- By:
- Publication type:
- Article
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3501, doi. 10.1007/s12325-022-02166-6
- By:
- Publication type:
- Article
A First-in-Human Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Two-Year Clinical and Imaging Outcomes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics and Exposure-Response Analysis of Venetoclax + Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 8, p. 3635, doi. 10.1007/s12325-022-02170-w
- By:
- Publication type:
- Article